Eli Lilly to buy Ajax Therapeutics for up to $2.3 billion
CNBC Top News ·
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured in Branchburg, New Jersey, on March 5, 2021. Mike Segar | Reuters Eli Lilly said on Monday it would buy privately held blood …
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured in Branchburg, New Jersey, on March 5, 2021. Mike Segar | Reuters Eli Lilly said on Monday it would buy privately held blood cancer treatment developer Ajax Therapeutics for up to $2.3 billion in cash. Ajax's lead asset, AJ1-11095, is an experimental once-daily oral treatment that is in early-stage testing for previously treated patients with myelofibrosis - a rare, chronic blood cancer where scar tissue builds up …
Original source: CNBC Top News